All Companies

Company Description Status Initial Datesort icon
<a href="/venture-capital/all-companies/renovis">Renovis</a> Discovery, development and commercialization of druts to treat neurological diseases and disorders Public 2000 View Profile
<a href="/venture-capital/all-companies/cgi-pharmaceuticals-inc">CGI Pharmaceuticals, Inc.</a> Developing small molecule therapeutics for multiple oncology and immunology-based indications Acquired 2001 View Profile
<a href="/venture-capital/all-companies/seahorse-bioscience-inc">Seahorse Bioscience, Inc.</a> XF instruments are the industry standard in cellular bioenergetic measurements. Private 2001 View Profile
<a href="/venture-capital/all-companies/selventa">Selventa</a> Pioneering the development of Systems Diagnostics (SysDx™). Private 2001 View Profile
<a href="/venture-capital/all-companies/morphotek-inc">Morphotek, Inc.</a> Genetically diverse organisms for agricultural, life science, and pharmaceutical use Acquired 2001 View Profile
<a href="/venture-capital/all-companies/adnexus-therapeutics">Adnexus Therapeutics</a> Developing new class of therapeutic compounds. Acquired 2002 View Profile
<a href="/venture-capital/all-companies/zalicus">Zalicus</a> Discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. Public 2002 View Profile
<a href="/venture-capital/all-companies/intellivid">IntelliVid</a> Machine intelligence for video security Acquired 2002 View Profile
<a href="/venture-capital/all-companies/aveo-pharmaceuticals-inc">AVEO Pharmaceuticals, Inc.</a> Discovering, developing and commercializing cancer therapeutics. Public 2003 View Profile
<a href="/venture-capital/all-companies/pervasis-therapeutics-inc">Pervasis Therapeutics, Inc.</a> Developing novel therapeutics to promote vascular repair. Private 2003 View Profile
<a href="/venture-capital/all-companies/epitome-biosystems">Epitome Biosystems</a> Developing novel protein measurement systems based on Protien Epitope Tag technology Acquired 2003 View Profile
<a href="/venture-capital/all-companies/acceleron-pharma-inc">Acceleron Pharma, Inc.</a> Discovering, developing and commercializing novel protein therapeutics for cancer and rare diseases. Public 2004 View Profile
<a href="/venture-capital/all-companies/black-duck-software-inc">Black Duck Software, Inc.</a> Providing the world’s only end-to-end platform for OSS Logistics. Private 2004 View Profile
<a href="/venture-capital/all-companies/ensemble-therapeutics-corporation">Ensemble Therapeutics Corporation</a> Deploying its proprietary chemistry platforms to develop a novel class of therapeutics known as “Ensemblins”. Private 2004 View Profile
<a href="/venture-capital/all-companies/ls9">LS9</a> Leading renewable chemical technology developer. Acquired 2005 View Profile
<a href="/venture-capital/all-companies/visen-medical-inc">VisEn Medical, Inc.</a> Pioneering a new era of in vivo imaging. Acquired 2005 View Profile
<a href="/venture-capital/all-companies/resolvyx-pharmaceuticals-inc">Resolvyx Pharmaceuticals, Inc.</a> Developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. Private 2005 View Profile
<a href="/venture-capital/all-companies/interactive-supercomputing-corporation">Interactive Supercomputing Corporation</a> Software to enable applications transparent use of cluster supercomputers Acquired 2005 View Profile
<a href="/venture-capital/all-companies/intio">INTIO</a> Developing a software platform to support the emerging interventional oncology market. Private 2005 View Profile
<a href="/venture-capital/all-companies/concert-pharmaceuticals-inc">Concert Pharmaceuticals, Inc.</a> Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. Public 2006 View Profile